2933935-13-6
Chemical Structure
KRASG12D-IN-5
- CAS No.: 2933935-13-6
- Formula:C34H31F5N6O2
- Molecular Weight:650.64
InChIKey: SUQIZNDQWXDZBR-VLLKXRCKSA-N
SMILES: OC1=CC2=C(C(C#C)=C(C=C2)F)C(C3=C(F)C4=C(C=N3)C(N5[C@H](C(F)F)[C@H]6CC[C@](C5)([H])N6)=NC(OC[C@]78C[C@@H](F)CN7CCC8)=N4)=C1
Biological Activity: KRASG12D-IN-5 (Compound 241) is an orally active KRAS(G12D) inhibitor with an IC50 of 11 nM. KRASG12D-IN-5 has potent anticancer activity with no significant cytotoxicity against BxPC-3 (WT), KRAS mutation AsPC-1 (G12D) and MIAPaCa-2 cells (G12C) with CC50s of 10.37, 0.76 and 0.3 μM, respectively. KRASG12D-IN-5 can be used for cancer research, such as lung, pancreatic and colorectal cancer[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
KRASG12D-IN-5 | KRASG12D-IN-5 (Compound 241) is an orally active KRAS(G12D) inhibitor with an IC50 of 11 nM. KRASG12D-IN-5 has potent anticancer activity with no significant cytotoxicity against BxPC-3 (WT), KRAS mutation AsPC-1 (G12D) and MIAPaCa-2 cells (G12C) with CC50s of 10.37, 0.76 and 0.3 μM, respectively. KRASG12D-IN-5 can be used for cancer research, such as lung, pancreatic and colorectal cancer. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
